The argument for pharmaceutical policy

Pharmacy World and Science

Volumn 27, Issue 1, 2005, Pages 7-12

  Traulsen, Janine Morgall ^a   Almarsdóttir, Anna Birna ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Health care; Pharmaceutical policy; Pharmacy administration

Indexed keywords

NON PRESCRIPTION DRUG;

DRUG DISTRIBUTION; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PRACTITIONER; HUMAN; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRESCRIPTION; PUBLIC HEALTH; REVIEW; WORLD HEALTH ORGANIZATION;

DRUG INDUSTRY; HEALTH PERSONNEL; HEALTH POLICY; LEGISLATION, DRUG; PHARMACEUTICAL SERVICES; POLITICS; PUBLIC HEALTH;

EID: 14944350035     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-004-5151-2     Document Type: Review

References (21)

1. Andersen NV. The community pharmacy monopoly up for debate in the Folketing (Danish Parliament) [in Danish]. Politiken daily newspaper, Saturday 19 June 2004.
2. Larsen JB, Traulsen JM. The liberalization that didn't come [in Danish]. Lægemiddelforskning (the Bulletin of the Danish University of Pharmaceutical Sciences) 2003; 36-7.
3. JB Larsen 2004 The pharmaceutical distribution in Denmark-viewed in the light of deregulation. The Danish University of Pharmaceutical Sciences, Department of Social Pharmacy Copenhagen
4. A Anell J Hjelmgren 2001 The effects of deregulating community pharmacy - experiences from Iceland, Norway, and Denmark [in Swedish]. The Swedish Institute for Health Economics (IHE) Lund IHE working report no. 2001:3.
5. Anell A. The effects of deregulating community pharmacy-experiences from Iceland, Norway, and Denmark [in Swedish]. IHE working report. Lund: The Swedish Institute for Health Economics (IHE), in press.
6. G Mathisen 2004 Disagreement on foreign ownership [in Norwegian]. Norges Apotekerforenings Tidsskrift 01 4 6
7. S Strøm 2004 The community pharmacy reform [in Norwegian]. Norges Apotekerforenings Tidsskrift 01 8 9
8. ECON Analyse 2004 Evaluation of the pharmaceutical legislation and the index price system. ECON Analyse Oslo ECON-report no. 2004-10. ISBN 82-7645-686-3.
9. KR Brekke A Grasdal TH Holmås F Steen K Sunnevåg 2003 Evaluation of new pharmaceutical legislation and the index price system [in Norwegian]. Rokkansenteret Bergen ISBN 82-0895-021-4.
10. J McKinlay J Arches 1985 Towards the proletarianization of physicians. Int J Health Serv 15 161 95
11. JM Traulsen P Bissell 2004 Theories of professions and the pharmacist. Int J Pharm Pract 12 107 14
12. CD Hepler LM Strand 1991 Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47 533 43
13. RJ Cipolle LM Strand PC Morley 1998 Pharmaceutical care practice. McGraw Hill New York
14. KR Brekke A Grasdal TH Holmås F Steen K Sunnevåg 2004 Evaluation of new pharmaceutical legislation and the index price system [in Norwegian]. Norges Apotekerforenings Tidsskrift 01 12 5
15. J Gabe M Bury MA Elston 2004 Key concepts in medical sociology. Sage Publications London ISBN 0-7619-7441-5.
16. P Davis 1997 Managing medicines: public policy and therapeutic drugs. Open University Press Buckingham ISBN 0-335-19292-0.
17. J Abraham G Lewis 2002 Citizenship, medical expertise and the capitalist regulatory state in Europe. Sociology 36 1 67 88
18. J Abraham 1997 The science and politics of medicines regulation M Elston The sociology of medical science and technology. Blackwell Publishing Oxford
19. JA Johnson JL Bootman 1995 Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 155 18 1949 56
20. T McKeown 1979 The role of medicine: dream, mirage or nemesis? Blackwell Publishing Oxford
21. Fidler DP 21 2001 The globalization of public health: the first 100 years of international health diplomacy. Bull. World Health Organ 79 842 9